Skip to main content
. 2021 Sep 19;6(1):149–158. doi: 10.1002/ags3.12508

TABLE 3.

Risk factors for overall survival

Factors N = 203 Univariate Multivariate
5Y‐survival P value HR 95% CI P value
Age (y)
≥65 129 72.3% .21
<65 74 74.5%
Gender
Male 157 73.6% .62
Female 46 72.1%
Hepatitis virus
Nonvirus 66 68.9% .14
HCV antibody 99 72.6%
HBV antigen 38 81.2%
AAC (mm3)
≥250 150 67.9% <.01 2.51 1.24‐5.09 .01
<250 53 88.2%
Total bilirubin (mg/dL)
≥1.5 11 36.4% <.01
<1.5 192 75.4%
ALT (IU/L)
≥50 45 79.4% .25
<50 158 71.3%
Albumin (mg/dL)
≥4.0 121 81.4% <.01 1.98 1.21–3.22 <.01
<4.0 82 59.6%
PT (%)
≥80 154 72.2% .70
<80 49 76.3%
ICG‐R15 (%)
≥10 130 68.6% .04
<10 73 81.2%
Operation time (min)
≥360 76 61.7% <.01
<360 127 77.8%
Blood loss (mL)
≥400 75 73.2% <.01 1.64 1.01–2.67 .04
<400 128 81.2%
DCP (mAU/mL)
≥40 114 66.3% .06
<40 89 81.8%
AFP (ng/mL)
≥40 60 60.0% .03 2.49 1.48–4.17 <.01
<40 143 78.8%
Child–Pugh
Class A 190 73.6% .06
Class B 13 66.6%
Anatomical hepatectomy
Yes 57 82.5% .08
No 146 69.5%
Hepatectomy
Minor hepatectomy 175 77.8% <.01
Major hepatectomy 28 44.6%
Number of tumor
≥2 64 53.6% <.01 2.15 1.30–3.57 <.01
<2 139 82.3%
Tumor size (mm)
≥40 58 51.7% <.01 1.92 1.17–3.15 <.01
<40 145 82.1%
Poorly differentiated
Yes 20 56.3% .02
No 183 74.9%
Vascular invasion
Yes 39 50.2% <.01
No 164 78.1%
Serosal invasion
Yes 28 66.5% .30
No 175 74.2%

Abbreviations: ACC, abdominal aortic calcification; AFP, a‐fetoprotein; ALT, alanine aminotransferase; DCP, des‐gamma‐carboxy protein; HCC, hepatocellular carcinoma; HCV, hepatitis virus type C; ICGR‐15, indocyanine green clearance test; PT, prothrombin time.